AzurRx BioPharma, Inc.
AZRX · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $12 | $54 | $23 | $19 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $2 | $0 |
| Enterprise Value | $12 | $54 | $25 | $18 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$16 | -$27 | -$14 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$18 | -$33 | -$15 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -5.33 | -5.903 | -6.77 | -8.77 |
| % Growth | 9.7% | 12.8% | 22.8% | – |
| Operating Cash Flow | -$9 | -$11 | -$14 | -$11 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$11 | -$14 | -$11 |